Home
>
National Drug Code (NDC)
>
CELESTONE SOLUSPAN
CELESTONE SOLUSPAN - 0085-0566-05 - (Betamethasone Acetate and Betamethasone Sodium Phosphate)
Drug Information of CELESTONE SOLUSPAN
| Product NDC: | 0085-0566 |
| Proprietary Name: | CELESTONE SOLUSPAN |
| Non Proprietary Name: | Betamethasone Acetate and Betamethasone Sodium Phosphate |
| Active Ingredient(s): | 3; 3 mg/mL; mg/mL & nbsp; Betamethasone Acetate and Betamethasone Sodium Phosphate |
| Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CELESTONE SOLUSPAN
| Product NDC: | 0085-0566 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA014602 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19650315 |
Package Information of CELESTONE SOLUSPAN
| Package NDC: | 0085-0566-05 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 BOX (0085-0566-05) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Information of CELESTONE SOLUSPAN
| NDC Code | 0085-0566-05 |
| Proprietary Name | CELESTONE SOLUSPAN |
| Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (0085-0566-05) > 5 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 0085-0566 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Betamethasone Acetate and Betamethasone Sodium Phosphate |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
| Start Marketing Date | 19650315 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
| Strength Number | 3; 3 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
